---
title: "CHINAHEALTHWISE reduced its holdings in YUNFENG FIN by 500,000 shares, realizing 1.56 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282435373.md"
description: "CHINAHEALTHWISE announced that on April 10th, it sold a total of 500,000 shares of YUNFENG FIN for approximately HKD 1.56 million, equivalent to an average price of HKD 3.13 per share. It is estimated that the sale will result in a pre-tax loss of approximately HKD 16,000. After the completion, the company still holds 2.684 million shares of YUNFENG FIN"
datetime: "2026-04-12T06:14:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282435373.md)
  - [en](https://longbridge.com/en/news/282435373.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282435373.md)
---

# CHINAHEALTHWISE reduced its holdings in YUNFENG FIN by 500,000 shares, realizing 1.56 million

CHINAHEALTHWISE (00348.HK) announced that on April 10, it sold a total of 500,000 shares of YUNFENG FIN (00376.HK) for a total consideration of approximately HKD 1.56 million, equivalent to an average price of HKD 3.13 per share. It is estimated that the sale will result in a pre-tax loss of approximately HKD 16,000. After the completion, the company still holds 2.684 million shares of YUNFENG FIN

### Related Stocks

- [00348.HK](https://longbridge.com/en/quote/00348.HK.md)
- [00376.HK](https://longbridge.com/en/quote/00376.HK.md)

## Related News & Research

- [Jack Ma-Backed Insurer Yunfeng Financial Launches Gold Token](https://longbridge.com/en/news/286296964.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md)
- [Sayulita Wellness Retreat Launches Dedicated Ibogaine Treatment Platform to Champion Clinical Safety in Psychedelic Care](https://longbridge.com/en/news/287137533.md)
- [BioInvent to Host Virtual KOL Event to Discuss BI-1808 for the Treatment of Ovarian Cancer, on May 27, 2026](https://longbridge.com/en/news/287043048.md)